Summary & Overview
HCPCS J0134: Injection, Acetaminophen (Fresenius Kabi), 10 mg
HCPCS Level II code J0134 denotes a 10 mg injection of acetaminophen produced by Fresenius Kabi and identified as not therapeutically equivalent to J0131. This medication-level HCPCS code matters nationally because it distinguishes product-specific billing for parenteral acetaminophen formulations, which affects reimbursement, inventory management, and billing accuracy in hospitals, infusion centers, and emergency departments. Major payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what this code represents clinically and operationally, how it is used across typical sites of service, and where it diverges from other acetaminophen HCPCS codes due to product-specific equivalency notes. The publication also summarizes common payer coverage considerations and the types of benchmarks and policy updates relevant to HCPCS medication coding. Where input data is incomplete, the text notes “Data not available in the input.” The goal is to provide clear, actionable reference material for coding specialists, revenue cycle staff, and policy analysts handling billing for parenteral acetaminophen products.
Billing Code Overview
HCPCS Level II code J0134 describes an injection of acetaminophen (Fresenius Kabi), 10 mg, explicitly noted as not therapeutically equivalent to J0131. This code represents billing for a parenteral formulation of acetaminophen supplied by Fresenius Kabi.
Service Type: Injection / Parenteral Medication
Typical Site of Service: Outpatient infusion clinic, hospital inpatient or outpatient setting, emergency department, or other clinical locations where intravenous or intramuscular medications are administered.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for moderate to severe acute pain or postoperative pain where oral acetaminophen is not feasible or absorption is unreliable. The patient may have undergone abdominal surgery, orthopedic joint replacement, or experienced severe nausea/vomiting, and requires intravenous acetaminophen (brand: Fresenius Kabi) dosed per institutional protocol. The clinical workflow: the prescribing clinician documents indication and dose in the medical record; pharmacy verifies allergies, prepares the J0134 product in a sterile environment and labels it for administration; nursing confirms identity and administers the intravenous injection/infusion per facility policy; pain scores and vital signs are monitored post-administration; administration is charted in the medication administration record (MAR) and billing is submitted using HCPCS code J0134 with applicable modifiers reflecting payer, service circumstances, or drug handling (for example, a discarded drug amount or billing exception).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | When part of a single-use vial is discarded and payer allows separate reporting of discarded portion |